Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	64.5	73.87	1.32	60.71	53.42	126.95
Depreciation & Amortization	80.69	80.41	84.86	85.54	32.6	18.14
Stock-Based Compensation	30.88	27.76	26.76	17.57	17.91	16.56
Other Adjustments	-3.48	-8.03	7.29	-22.75	19.63	13.26
Change in Receivables	11.66	2.08	18.77	-16.37	3.87	-34.61
Changes in Inventories	17.41	15.81	6.11	-17.86	-14.58	-10.12
Changes in Accounts Payable	-14.79	-15.02	-36.29	-19.16	18.18	8.27
Changes in Accrued Expenses	5.8	14.43	2.61	18.94	4.5	10.39
Changes in Other Operating Activities	-7.69	-19.35	-0.33	10.2	-8.4	-10.44
Operating Cash Flow	187.06	171.95	111.09	116.83	127.13	138.4
Operating Cash Flow Growth	20.79%	54.79%	-4.91%	-8.10%	-8.14%	-3.31%
Capital Expenditures	-1.2	-0.73	-0.55	-0.41	-2.05	-3.69
Purchases of Investments	-629.45	-688.01	-101.62	-406.99	-311.57	-95.89
Proceeds from Sale of Investments	547.7	498.87	370.9	190.74	543.4	363.42
Payments for Business Acquisitions	-	-	-	-	-311.69	-298.54
Investing Cash Flow	-82.94	-189.87	268.73	-216.66	-81.91	-34.7
Short-Term Debt Issued	-	-	93	-	-	-
Short-Term Debt Repaid	-	-	-93	-	-	-
Long-Term Debt Issued	-	-	-	-	0.8	-
Long-Term Debt Repaid	-	-	-402.5	-	-138.32	-0.8
Net Long-Term Debt Issued (Repaid)	-	-	-402.5	-	-137.52	-0.8
Issuance of Common Stock	15.66	14.91	6.61	12.42	7.1	4.36
Repurchase of Common Stock	-4.76	-2.72	-1.99	-22.9	-	-
Net Common Stock Issued (Repurchased)	10.9	12.19	4.62	-10.48	7.1	4.36
Financing Cash Flow	-11.5	12.19	-397.88	-10.48	-130.42	3.56
Net Cash Flow	92.62	-5.72	-18.07	-110.31	-85.21	107.26
Beginning Cash & Cash Equivalents	52.09	75.05	93.12	203.43	288.64	181.38
Ending Cash & Cash Equivalents	144.71	69.33	75.05	93.12	203.43	288.64
Free Cash Flow	185.87	171.23	110.53	116.41	125.08	134.71
Free Cash Flow Growth	8.55%	54.91%	-5.05%	-6.93%	-7.15%	-4.96%
FCF Margin	27.94%	25.87%	18.19%	17.45%	21.57%	25.89%
Free Cash Flow Per Share	3.30	3.06	1.99	1.89	2.30	2.51
Levered Free Cash Flow	144.71	149.42	-344.78	137.97	-53.84	138.69
Unlevered Free Cash Flow	130.56	137.19	53.9	123.35	93.06	143.29

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q